Janiczek Wealth Management, LLC Grifols Sa Transaction History

Janiczek Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$10.6 - $13.28 $14,310 - $17,928	-1,350 Reduced 76.88%	406 $4,000
Q1 2022 May 05, 2022	SELL	$10.37 - $12.73 $22,025 - $27,038	-2,124 Reduced 54.74%	1,756 $21,000
Q4 2021 Feb 02, 2022	BUY	$10.21 - $15.27 $20,399 - $30,509	1,998 Added 106.16%	3,880 $44,000
Q3 2021 Oct 19, 2021	SELL	$14.07 - $17.3 $4,769 - $5,864	-339 Reduced 15.26%	1,882 $27,000
Q2 2021 Jul 28, 2021	BUY	$16.62 - $18.94 $6,947 - $7,916	418 Added 23.18%	2,221 $39,000
Q1 2021 Apr 28, 2021	BUY	$15.15 - $19.78 $19,331 - $25,239	1,276 Added 242.13%	1,803 $31,000
Q4 2020 Jan 26, 2021	BUY	$16.86 - $19.67 $8,885 - $10,366	527 New	527 $10,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.